OR WAIT null SECS
July 02, 2017
The BIOSTAT STR single-use bioreactor family from Sartorius Stedim Biotech is based on a conventional stirred-tank design.
Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.
Materials and equipment innovations have advanced tablet coating from sugar to copolymers and simplified pharma production.
New ADC therapies must overcome manufacturing challenges to reach market.
As commercial manufacturing considers single-use materials, a look shows how industry moved to the technology.
The more pharma science and technology change, the more business and policy concerns stay the same.
Biotech-based therapies and a move to single-use processes highlight recent industry changes.
ISPE measures impact of biotechnology and globalization on personalized medicine.
Drug costs, biosimilars, and cloud-based technologies will shape the pharmaceutical industry in the years to come.
Advancements in cell culture and protein technology have opened the door for new therapies.